The Need of Pharmacovigilance Activities in Yemen

Mohammed Ahmed Alshakka Abdulkareem Mohammed Alsh

Authors

Mohammed Ahmed Alshakka Abdulkareem Mohammed Alsh

Keywords:

adverse drug reaction, drug safety, pharm-acovigilance, safety monitoring, yemen

Abstract

Adverse drug reactions, medication errors and other drug-related problems are the leading causes of hospital-lisation and are associated with a huge economic burden and significant human suffering. This serious issue of medication therapy also contributes to morbidity and mortality. At present, the monitoring of adverse drug reactions was started in Yemen by establishing a pharmacovigilance centre in 2011. Till now there is no published information about its work , number of reports and how they process it. The country and public are facing with many safety problems related to drug smuggling, counterfeit drugs, improper and irrational use of drugs, importation of unnecessary drugs and medical errors. Therefore, it is necessary to make serious steps and active regulations in Yemen to ensure patients and public safety in relation to medicines use.

Downloads

How to Cite

The Need of Pharmacovigilance Activities in Yemen. (2014). Global Journal of Medical Research, 14(28), 9-13. https://medicalresearchjournal.org/index.php/GJMR/article/view/

Download Citation

References

(1972) International Drug Monitoring: The Role of National Centres (WHO Technical Report Series No. 498).

P. Pouyanne, F. Haramburu, J. Imbs, B. Begaud (2000) Admissions to hospital caused by adverse drug reactions: cross sectional incidence study. 320, 1036.

Wasserfallen J, Livio F, Buclin T, Tillet L, Yersin B, Biollaz J (2001) Rate, type, and cost of adverse drug reactions in emergency department admissions. 12, 442-447.

Classen DC, Pestotnik SL, Evans RS, Lloyd JF, Burke JP (1997) Adverse drug events in hospitalised patients Excess length of stay, extra costs, and attributable mortality. 277, 301-306.

Suh DC, Woodall BS, Shin SK, Hermes-De ER (2000) Clinical and Economic Impact of Adverse Drug Reactions in Hospitalized Patients. 34, 1373-1379.

Classen DC, Pestotnik SL, Evans RS (1997) Adverse drug events in hospitalized patients. 277(4), 301.

Jason Lazarou, Bruce Pomeranz, Paul Corey (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. 279(15), 1200. https://doi.org/10.1001/jama.279.15.1200

A. Lee, Shl Thomas (2003) Adverse drug reactions. 33-46.

Pourseyed S, Fattahi F, Pourpak Z, Gholami K, Shariatpanahi SS, Moin A, Kazemnejad A, Moin M (2008) Adverse drug reactions in patients in an Iranian department of internal medicine.

Gholami K, Shalviri G (1999) Factors associated with preventability, predictability, and severity of adverse drug reactions. 33(2), 236-40.

R. Arulmani, S. Rajendran, B. Suresh (2008) Adverse drug reaction monitoring in a secondary care hospital in South India. 65(2), 210-216.

Al-Malaq HM, Al-Aqeel SA, Al-Sultan MS (2008) Adverse drug reactions related hospitalization identified by discharge ICD-9 codes in a univeristy hospital in Riyadh. 2008(8), 1145-1150.

N. Jha, O. Bajracharya, T. Namgyal (2007) Prevalence of adverse drug reactions with commonly prescribed drugs in different hospitals of Kathmandu valley. 5(4), 504-510.

S. Olsson (2001) The need for pharmacovigilance In: Gupta SK Pharmacology and therapeutics in the new millennium. 2001, 502-508.

(2002) Safety of medicines: A guide to detecting and reporting adverse drug reactions.

Yaseen Alqubati Yaseen Alqubati,Shaher Medicine prices in yemen Available eys/200607YE/survey_report.

(2003) 2007.

Alshakka Mohammed (2008) Importance of Adverse Drug Reactions Monitoring in Yemen.

(2007) Annual report of Suprame Board of Drugs and Medical Appliances Yemen.

Melrose D (1982) Bitter pills: medicines and the third world poor.

The drugs (1987) The rational use of drugs. Report of a conference of experts, Nairobi, 25-29 November 1985. 25-29.